Protara Therapeutics, Inc.TARANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank92
3Y CAGR-1.4%
5Y CAGR+13.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.4%/yr
vs +26.6%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
-28.1pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $64.19M | +30.6% |
| 2024 | $49.15M | +13.6% |
| 2023 | $43.27M | -35.5% |
| 2022 | $67.06M | +41.2% |
| 2021 | $47.49M | +38.7% |
| 2020 | $34.25M | +124.5% |
| 2019 | $15.25M | -41.5% |
| 2018 | $26.08M | -13.7% |
| 2017 | $30.21M | +5.7% |
| 2016 | $28.58M | - |